METHOTREXATE
- Product NDC
- 47781-482
- 11-digit product format
- 477810482
- Labeler code
- 47781
- Product ID
- 47781-482_974dbc29-e562-002a-df78-913da27066f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methotrexate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Alvogen Inc.
- Application
- ANDA209787
- Marketing category
- ANDA
- Marketing start
- 2022-04-27
- Marketing end
- 0000-00-00
- Substance
- METHOTREXATE SODIUM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-482-01 | 47781048201 | 100 TABLET in 1 BOTTLE (47781-482-01) | 100 tablet | 2022-04-27 | 0000-00-00 | No | No | Current |